Overview
- - The WHO lists BA.3.2 as a Variant under Monitoring, and a CDC assessment confirms detections in 23 countries across multiple regions.
- - Lab studies cited by the CDC show BA.3.2 carries about 70–75 spike‑protein mutations that help it evade antibodies, which could make current vaccines less effective at blocking infection.
- - Spread is uneven in Europe, with reports of roughly one‑third of sequenced cases in parts of Northern Europe during winter, and Germany’s share dropping from about 38% around the New Year to near 5% by mid‑March.
- - In the United States the lineage remains rare at under 0.2% of sequenced cases, though it has been found in travelers’ swabs, clinical samples, and wastewater from 25 states.
- - Health experts report no sign of increased severity, and they say vaccines still help prevent serious illness as authorities promote testing, risk‑based masking, and boosters for high‑risk groups such as those guided by Germany’s STIKO.